Shree Pacetronix Price Movement Clarification
Shree Pacetronix replied to BSE's price-movement query. It stated all material info is disclosed under Reg 30 and the move is purely market-driven.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements with these filters
Shree Pacetronix replied to BSE's price-movement query. It stated all material info is disclosed under Reg 30 and the move is purely market-driven.
Shree Pacetronix notified shareholders about their upcoming 38th AGM and the availability of the Annual Report via the company website for those with unregistered email IDs.
Shree Pacetronix Ltd submitted its 38th Annual Report for the financial year 2025-2026. The 38th Annual General Meeting is scheduled for September 29, 2026.
Shree Pacetronix Ltd has issued notice for its 38th Annual General Meeting to be held on 29th September, 2026. The agenda includes director and auditor appointments.
Shree Pacetronix Ltd announced the re-appointment of Mr. Akash Sethi as Joint Managing Director, and Ms. Manali Tongia and Ms. Somya Chhabra as Independent Directors.
Shree Pacetronix Ltd has scheduled its 38th Annual General Meeting for September 29, 2026. Consequently, the company's register of members will remain closed from September 23, 2026.
Shree Pacetronix Ltd reported revenue from operations of ₹4.9 Cr (-7.5% YoY) and net profit of ₹0.8 Cr (+14.3% YoY) for Q1 FY27.
Shree Pacetronix approved its Q1 FY2027 financial results, scheduled its 38th AGM for September 29, 2026, and reappointed key managerial personnel and directors.
Shree Pacetronix Ltd will hold a board meeting on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Shree Pacetronix Ltd submitted its quarterly shareholding pattern for the period ended June 30, 2026, as required under SEBI Regulation 31(1)(b).
Promoter Akash Sethi acquired 1,78,000 shares of Shree Pacetronix via off-market transfer. His stake rose from 8.76% to 13.51%, signaling increased promoter commitment.
Shree Pacetronix Limited reported zero deviation in the utilization of ₹1.52 Crore raised through preferential issues. The funds were deployed for capital expenditure and general corporate purposes.
Shree Pacetronix confirmed non-applicability of the Annual Secretarial Compliance Report for FY2026. The company remains exempt as its capital and net worth are below regulatory thresholds.
Shree Pacetronix appointed Agarwal Patel & Sinhal as Statutory Auditors for five years. Apeksha Medatwal & Associates was also named Internal Auditor for FY 2026-2027.
Shree Pacetronix Ltd reported revenue from operations of ₹5.4 Cr (+25.6% YoY) and net profit of ₹1.1 Cr (+120.0% YoY) for Q4 FY26.
Shree Pacetronix reported consolidated annual revenue of ₹21.76 Crore for FY2026. The board approved these audited results alongside a standalone net profit of ₹3.02 Crore.
Shree Pacetronix Ltd approved audited financial results and appointed new statutory and internal auditors. The board also recommended material related party transactions for shareholder approval.
Shree Pacetronix scheduled a board meeting on May 25, 2026. Directors will consider and approve audited standalone and consolidated financial results for fiscal 2026.
Shree Pacetronix Limited received BSE listing approval for 75,150 equity shares following a promoter warrant conversion. The approval formalizes the inclusion of these shares for trading.
Shree Pacetronix Ltd confirmed it does not fall under the Large Corporate category for the financial year 2026 as per SEBI criteria. The company reported outstanding borrowings of ₹2.61 Crore as of March 31, 2026.
Shree Pacetronix Ltd clarified to BSE that recent share price movements are purely market-driven. The company confirmed it has disclosed all price-sensitive information as per SEBI regulations and remains unaware of any specific reasons for the volatility. The management reiterated its commitment to regulatory compliance and timely disclosures.